Navigation Links
Pharsight Achieves First License Sale for Public-Source Database
Date:8/27/2007

deling and support our client's critical drug development decisions."

About Pharsight Public-Source Meta-databases

Pharsight meta-databases provide highly structured quantitative information from the public-source scientific literature that can be used to understand the competitive landscape for a particular therapeutic area and indication. Meta-databases provide a publicly available starting point for model-based drug development approaches, often combining proprietary data on a specific compound with literature data of its likely competitors, to manage risk and address specific drug development program questions concerning dose selection, efficient and effective trial design, and "go/no-go" decisions. Pharsight offers meta-databases in nine therapeutic areas, covering 20 disease indications. Additional information is available at http://www.pharsight.com/services/scs_home.php.

About Pharsight Corporation

Pharsight Corporation develops and markets integrated products and services that enable pharmaceutical and biotechnology companies to achieve significant and enduring improvements in the development and use of therapeutic products. The company's goal is to help customers reduce the time, cost and risk of drug development, as well as optimize the post-approval marketing and use of pharmaceutical products.

Pharsight's approach enhances the fundamental element of drug development success: strong decision-making. By adopting the Pharsight approach, customers acquire a new decision-making process with the potential to systematically improve every level and phase of their business and scientific processes. Pharsight is headquartered in Mountain View, California. Information about Pharsight is available at http://www.pharsight.com.

Forward Looking Statements

The statements in this press release related t
'/>"/>

SOURCE Pharsight Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Inacom Information Systems achieves Cisco Systems Partner -Gold Certified status
2. Third Wave Achieves Milestone, Delivers 200,000 SNP Assays to RIKEN In Japan
3. The Genesis of Gendicine: The Story Behind the First Gene Therapy
4. Midwest life science stocks sizzle in a tepid first quarter
5. Morgridge Institute for Research seeks first CEO
6. Sonic Foundry reports first cash-positive quarter
7. Angel investors commit $12.7B in first half of `06
8. Aurora team implants Wisconsins first total artificial heart
9. First half of 2006 roundup: Big Pharma trumps biotech
10. GE announces first installation of Discovery VCT
11. GE Healthcare enjoys robust growth in first quarter
Post Your Comments:
*Name:
*Comment:
*Email: